PRGO Q2 2020 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$949M-17.4% YoY

Gross Profit

$347M36.6% margin

Operating Income

$63M6.6% margin

Net Income

$61M6.4% margin

EPS (Diluted)

$0.44

QoQ Revenue Growth

-12.4%

Cash Flow

Operating Cash Flow

$291M

Free Cash Flow

$232M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$12.1B

Total Liabilities

$6.2B

Stockholders' Equity

$5.9B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$949M	$1.1B	-17.4%
Gross Profit	$347M	$431M	-19.4%
Operating Income	$63M	$55M	+14.0%
Net Income	$61M	$9M	+573.3%

Revenue Segments

Consumer Self-Care Americas

$628M51%

Consumer Self-Care International

$321M26%

RX Pharmaceuticals

$270M22%

Geographic Segments

UNITED STATES

$849M69%

Europe

$312M25%

Other Geographical Areas

$59M5%

IRELAND

$8M1%